SCHEMBL14036266

SCHEMBL14036266

C/C=C\c1c([C@H](O)[C@@H](CC)NC(C)C)ccc(O)c1NC=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.47
▸ ADRB2 P07550 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP2D6 P10635 2/20 0.47
▸ TSHR P16473 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ PTGS2 P35354 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ ADRB1 P08588 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ DRD2 P14416 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ HIF1A Q16665 3/20 0.46
▸ GAA P10253 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11844944 0.67 ADRB2 (0.55) KDM4EADRB2LMNACYP1A2CYP2D6
Hydrochloric Acid SCHEMBL11853153 0.66 KDM4E (0.54) KDM4EADRB2LMNACYP1A2CYP2D6
Procaterol SCHEMBL29390065 0.64 ADRB2 (1.00) KDM4EADRB2LMNACYP1A2CYP2D6
SCHEMBL11666276 0.64 ADRB2 (0.47) KDM4EADRB2LMNACYP1A2CYP2D6
Procaterol SCHEMBL30505289 0.64 ADRB2 (1.00) KDM4EADRB2LMNACYP1A2CYP2D6
Procaterol SCHEMBL28926423 0.64 ADRB2 (1.00) KDM4EADRB2LMNACYP1A2CYP2D6
Procaterol SCHEMBL4632 0.64 ADRB2 (1.00) KDM4EADRB2LMNACYP1A2CYP2D6
Procaterol SCHEMBL29445557 0.64 ADRB2 (1.00) KDM4EADRB2LMNACYP1A2CYP2D6
Procaterol SCHEMBL4633 0.64 ADRB2 (1.00) KDM4EADRB2LMNACYP1A2CYP2D6
Procaterol SCHEMBL14012960 0.64 ADRB2 (1.00) KDM4EADRB2LMNACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008144565-A1 TRANSDERMAL DELIVERY DEVICES ASSURING AN IMPROVED RELEASE OF AN ACTIVE PRINCIPLE THROUGH A BIOLOGICAL INTERFACE TTI ELLEBEAU, INC. (JP) 2008-11-27 — — WO disclosed
Send feedback